IP Library Granted Patent US 12,174,196
Granted Patent B2
US 12,174,196 · App. 18/598,736 · Granted Dec 24, 2024

Methods and compositions for protein sequencing

Inventors: Brian Reed (Madison, CT); Jeremy Lackey (Foster City, CA); Haidong Huang (Madison, CT)
Assignee: Quantum-Si Incorporated
G01N33/581C07K14/47C07K19/00C12Q1/6806G01N1/28G01N21/6428G01N33/58G01N33/582G01N33/6821G01N33/6824G16B25/10G16B40/00G16B40/10G16B50/30G01N2021/6439G01N2458/00G16B30/00G16B50/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,174,196
App. No.
18/598,736
Granted
Dec 24, 2024
Kind
B2
Abstract

Aspects of the application provide methods of identifying and sequencing proteins, polypeptides, and amino acids, and compositions useful for the same. In some aspects, the application provides methods of obtaining data during a degradation process of a polypeptide, and outputting a sequence representative of the polypeptide. In some aspects, the application provides amino acid recognition molecules comprising a shielding element that enhances photostability in polypeptide sequencing reactions.

Claims (35)

1. A method of sequencing a polypeptide, the method comprising:

contacting a single polypeptide molecule in a reaction mixture with a composition comprising one or more terminal amino acid recognition molecules and a cleaving reagent, wherein the single polypeptide molecule is immobilized to a surface through a non-covalent linkage group; and

detecting a series of signal pulses indicative of association of the one or more terminal amino acid recognition molecules with a terminus of the single polypeptide molecule in the presence of the cleaving reagent, wherein the series of signal pulses is indicative of a series of amino acids exposed at the terminus over time as a result of terminal amino acid cleavage by the cleaving reagent.

2. The method of claim 1 , wherein association of the one or more terminal amino acid recognition molecules with each type of amino acid exposed at the terminus produces a characteristic pattern in the series of signal pulses that is different from other types of amino acids exposed at the terminus.

3. The method of claim 2 , wherein the characteristic pattern comprises a portion of the series of signal pulses.

4. The method of claim 2 , wherein a signal pulse of the characteristic pattern corresponds to an individual association event between a terminal amino acid recognition molecule and an amino acid exposed at the terminus.

5. The method of claim 4 , wherein the characteristic pattern is indicative of the amino acid exposed at the terminus of the single polypeptide molecule and an amino acid at a contiguous position.

6. The method of claim 2 , wherein signal pulses of the characteristic pattern comprise a mean pulse duration of between about 10 milliseconds and about 100 milliseconds or between about 100 milliseconds and about 500 milliseconds.

7. The method of claim 1 , wherein at least one of the one or more terminal amino acid recognition molecules comprises a degradation pathway protein, a peptidase, an antibody, an aminotransferase, a tRNA synthetase, or an SH2 domain-containing protein or fragment thereof.

8. The method of claim 1 , wherein at least one of the one or more terminal amino acid recognition molecules comprises a detectable label.

9. The method of claim 8 , wherein the detectable label is a luminescent label.

10. The method of claim 1 , wherein sequencing comprises identifying at least a portion of all types of successive amino acids exposed at the terminus of the single polypeptide molecule while the single polypeptide molecule is being degraded by the cleaving reagent.

11. The method of claim 1 , wherein sequencing comprises identifying that an amino acid of the single polypeptide molecule comprises a post-translational modification.

12. The method of claim 11 , wherein the post-translational modification is selected from acetylation, ADP-ribosylation, caspase cleavage, citrullination, formylation, N-linked glycosylation, O-linked glycosylation, hydroxylation, methylation, myristoylation, neddylation, nitration, oxidation, palmitoylation, phosphorylation, prenylation, S-nitrosylation, sulfation, sumoylation, and ubiquitination.

13. The method of claim 11 , wherein the amino acid of the single polypeptide molecule comprises phospho-tyrosine or phospho-serine.

14. The method of claim 1 , wherein the non-covalent linkage group comprises a biotin molecule and an avidin protein.

15. The method of claim 14 , wherein the avidin protein comprises streptavidin, traptavidin, tamavidin, bradavidin, or xenavidin.

16. The method of claim 15 , wherein the avidin protein comprises streptavidin.

17. The method of claim 1 , wherein the surface comprises a surface of a substrate.

18. The method of claim 17 , wherein the substrate comprises an array of sample wells.

19. The method of claim 18 , wherein the single polypeptide molecule is immobilized within a sample well of the array.

20. The method of claim 18 , wherein the substrate comprises a plurality of polypeptide sequencing reactions, each polypeptide sequencing reaction occurring in an individual sample well of the array.

21. The method of claim 17 , wherein the substrate is an integrated device comprising a plurality of pixels, each pixel comprising a sample well and at least one photodetector.

22. The method of claim 17 further comprising, prior to contacting the single polypeptide molecule with the composition:

immobilizing the single polypeptide molecule to the surface of the substrate.

23. The method of claim 22 , wherein the immobilizing comprises:

contacting the substrate with the single polypeptide molecule, wherein the surface of the substrate comprises a polypeptide conjugating moiety and the single polypeptide molecule comprises a surface conjugating moiety, wherein the polypeptide conjugating moiety binds to the surface conjugating moiety to form the non-covalent linkage group.

24. The method of claim 23 , wherein the polypeptide conjugating moiety is a biotin molecule and the surface conjugating moiety is an avidin protein.

25. The method of claim 24 , wherein the avidin protein comprises streptavidin.

26. The method of claim 23 , wherein the polypeptide conjugating moiety is an avidin protein and the surface conjugating moiety is a biotin molecule.

27. The method of claim 26 , wherein the avidin protein comprises streptavidin.

28. A system comprising:

at least one hardware processor; and

at least one non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by the at least one hardware processor, cause the at least one hardware processor to perform the method of claim 1 .

29. At least one non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by at least one hardware processor, cause the at least one hardware processor to perform the method of claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2024
From: REED, BRIAN; LACKEY, JEREMY; HUANG, HAIDONG
To: QUANTUM-SI INCORPORATED
Reel/Frame 069198/0679 →
Continuity (5)
Continuation 16708989 · Dec 10, 2019
Continuation 16686028 · Nov 15, 2019
Provisional Application 62907507 · Sep 27, 2019
Provisional Application 62768076 · Nov 15, 2018
Related Publication 20240272169A1 · Aug 15, 2024
Cited By (2)
US 12,360,114 US 12,618,845